A woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care ...

Drs Ursula A. Matulonis and Gini F. Fleming discuss the state of endometrial cancer, the role of immunotherapy, and priorities for research in this field.

A government minister has admitted gynaecological delays leading to the death of Norfolk woman Carla Smith are "concerning".

Association Between Human Epidermal Growth Factor Receptor 2-Low Status and Time to Development of Brain Metastases Among Patients With Breast Cancer: A Retrospective Cohort Study A nationwide ...

Incidence and mortality in endometrial cancer (EC) have been steadily increasing in the ... addition to treatment of some advanced and recurrent ECs. On the basis of these findings alone, use of ...

The inquiry heard the patient was subsequently diagnosed with Stage IV cancer ... findings of his examination. Offering his condolences to the woman’s family, the consultant said an endometrial ...

A consultant gynaecologist who recommended Ann Summers products to an elderly patient with vaginal bleeding but who failed to carry out a thorough medical examination that might have detected cervical ...

When her doctor retired, she found a new doctor who ordered tests to assess her abnormal uterine bleeding ... patients come in with a copy of their ultrasound or MRI, and on that report, there are ...

Adenomyosis is a condition characterized by the invasion of endometrial glands and stroma into the myometrium ... High-intensity focused ultrasound (HIFU) ablation, a minimally invasive treatment, has ...

Dr. Alexander Kenigsberg at VCU Massey Cancer Center offered an inside look at how the Focal One High Intensity Focused Ultrasound (HIFU) works. The non-invasive technology uses precise targeting ...

The addition of glucagon-like peptide-1 receptor agonists to progestin therapy may help reduce endometrial cancer risk among certain women, according to study results. Findings presented at ...

A phase III trial of P-Sam versus physician's choice of chemotherapy is planned that will include patients with B7-H4-positive endometrial cancer whose disease has progressed following platinum ...